Berman Michael A 4
4 · CADENCE PHARMACEUTICALS INC · Filed May 21, 2009
Insider Transaction Report
Form 4
Berman Michael A
Director
Transactions
- Award
Common Stock
2009-05-20$9.57/sh+265$2,535→ 3,265 total(indirect: By Spouse) - Award
Common Stock
2009-05-20$9.58/sh+190$1,820→ 1,090 total(indirect: By Trust) - Award
Common Stock
2009-05-20$9.59/sh+120$1,151→ 1,320 total(indirect: By Trust)
Holdings
- 800(indirect: By Trust)
Common Stock
- 31,500
Common Stock
Footnotes (2)
- [F1]Mr. Berman is a trustee of this trust.
- [F2]The shares were purchased in multiple open market transactions at prices ranging from a low of $9.56 to a high of $9.57. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.